Holen Sie sich die Stockscreener-App
392.93
2.53%
9.70
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HUM?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$383.23
Offen:
$387.68
24-Stunden-Volumen:
257.21K
Relative Volume:
0.19
Marktkapitalisierung:
$47.20B
Einnahmen:
$137.20B
Nettoeinkommen (Verlust:
$1.15B
KGV:
42.05
EPS:
9.3439
Netto-Cashflow:
$1.27B
1W Leistung:
+0.82%
1M Leistung:
+8.03%
6M Leistung:
+106.22%
1J Leistung:
+29.40%
1-Tages-Spanne:
$386.32
$398.32
1-Wochen-Bereich:
$382.11
$403.15
52-Wochen-Spanne:
$163.11
$428.88
Humana Inc Stock (HUM) Company Profile
Firmenname
Humana Inc
Sektor
Branche
Telefon
(502) 580-1000
Adresse
101 E. MAIN STREET, LOUISVILLE, KY
Compare HUM vs UNH, CVS, ELV, CI
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HUM
Humana Inc
|
393.08 | 45.72B | 137.20B | 1.15B | 1.27B | 9.3439 |
UNH
Unitedhealth Group Inc
|
394.65 | 345.44B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
97.21 | 119.78B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
403.76 | 85.94B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
281.99 | 72.51B | 278.13B | 6.74B | 7.66B | 23.60 |
Humana Inc Stock (HUM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-02-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2026-01-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-12-05 | Hochstufung | Jefferies | Hold → Buy |
| 2025-10-14 | Eingeleitet | Goldman | Sell |
| 2025-09-22 | Eingeleitet | Evercore ISI | In-line |
| 2025-05-01 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2024-11-06 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-10-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-10-07 | Herabstufung | Jefferies | Buy → Hold |
| 2024-10-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-10-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-10-02 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-10-02 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-02 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-06-24 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-03-22 | Eingeleitet | Raymond James | Mkt Perform |
| 2024-03-13 | Herabstufung | Argus | Buy → Hold |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-26 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-01-25 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-12 | Hochstufung | Argus | Hold → Buy |
| 2023-11-08 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-07-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-06-23 | Herabstufung | Argus | Buy → Hold |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-12-13 | Hochstufung | Goldman | Neutral → Buy |
| 2022-10-26 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-09-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Eingeleitet | Bernstein | Mkt Perform |
| 2022-04-13 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-12-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-11-04 | Bestätigt | Barclays | Overweight |
| 2021-11-04 | Bestätigt | Credit Suisse | Outperform |
| 2021-11-04 | Bestätigt | Morgan Stanley | Overweight |
| 2021-11-04 | Bestätigt | Oppenheimer | Outperform |
| 2021-11-04 | Bestätigt | RBC Capital Mkts | Outperform |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-09-09 | Fortgesetzt | Barclays | Overweight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Neutral |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-01-04 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-10-02 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-16 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-06-05 | Eingeleitet | Goldman | Buy |
| 2020-01-03 | Bestätigt | JP Morgan | Overweight |
| 2019-10-18 | Eingeleitet | Mizuho | Buy |
| 2019-09-30 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-04-23 | Eingeleitet | UBS | Neutral |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-12-20 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-11-08 | Bestätigt | BofA/Merrill | Buy |
| 2018-09-13 | Eingeleitet | Barclays | Overweight |
| 2018-07-12 | Fortgesetzt | Morgan Stanley | Overweight |
| 2018-07-06 | Bestätigt | Piper Jaffray | Overweight |
| 2018-06-01 | Fortgesetzt | Citigroup | Buy |
| 2018-02-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-02-08 | Bestätigt | Leerink Partners | Outperform |
| 2018-01-12 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Humana Inc Aktie (HUM) Neueste Nachrichten
Humana names Dr. Shantanu Nundy chief medical officer - The Business Journals
Is UnitedHealth Finding a Better Path to Medicare Advantage Growth? - TradingView
Paralel Advisors LLC Invests $5.29 Million in Humana Inc. $HUM - MarketBeat
Wealthfront Advisers LLC Takes $3.40 Million Position in Humana Inc. $HUM - MarketBeat
Insurance moves: Sedgwick, ALKEME, ICW Specialty, C3, Humana, Ameritas - Insurance Business
Pzena U.S. Large Cap Value ETF's Humana Inc(HUM) Holding History - GuruFocus
Can Humana's Star Ratings Rebound Unlock MA Earnings Power? - Yahoo Finance
Humana taps physician executive as new chief medical officer - Healthcare Dive
Humana names Shantanu Nundy as chief medical officer - Investing.com
Humana names a practicing doctor to help shape its products and AI - Stock Titan
Humana Names Dr. Shantanu Nundy as Chief Medical Officer - Business Wire
Tocqueville Asset Management L.P. Buys Shares of 66,567 Humana Inc. $HUM - MarketBeat
Deutsche Bank AG Purchases New Stake in Humana Inc. $HUM - MarketBeat
Danske Bank A S Purchases New Position in Humana Inc. $HUM - MarketBeat
First National Bank of Omaha Takes Position in Humana Inc. $HUM - MarketBeat
Why Is Humana (NYSE:HUM) CenterWell Expansion in Focus After Q2? - Kalkine Media
Humana Inc. stock outperforms competitors despite losses on the day - MarketWatch
UnitedHealth Stock Looks Reasonable at 18.39X P/E: Should You Buy Now? - TradingView
290,935 Shares in Humana Inc. $HUM Acquired by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
Humana Inc. $HUM Shares Sold by Handelsbanken Fonder AB - MarketBeat
BlackRock Inc. Takes Position in Humana Inc. $HUM - MarketBeat
4,403,136 Shares in Humana Inc. $HUM Acquired by Pzena Investment Management LLC - MarketBeat
What the Medicare Advantage rebound signals for 2027 - Modern Healthcare
Humana (NYSE:HUM) Home Care Push Puts Valuation In Focus - Kalkine Media
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders? - Morningstar
Humana Inc. (HUM) Stock Analysis: Exploring a 7% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Diamond Hill Capital Management LLC Investment Advisor Makes New Investment in Humana Inc. $HUM - MarketBeat
Law firm investigates Humana directors for poss... - Pluang
7,351 Shares in Humana Inc. $HUM Purchased by S&CO Inc. - MarketBeat
Glenmark USA Agrees to USD 15.28 Mn Settlement With Humana Over Generic Drug Antitrust Claims - Medical Dialogues
Humana Stock Gains 1.1% as 600,000-Member Medicare Reset Tests Its 2028 Margin Plan - TechStock²
Oppenheimer Asset Management Inc. Makes New $9.05 Million Investment in Humana Inc. $HUM - MarketBeat
BlackRock Event Driven Equity Fund's Humana Inc(HUM) Holding History - GuruFocus
Humana Inc. stock outperforms competitors on strong trading day - MarketWatch
Brokers Set Expectations for Humana's Q3 Earnings (NYSE:HUM) - MarketBeat
Do Wall Street Analysts Like Humana Stock? - Yahoo Finance
Mirae Asset Global Investments Co. Ltd. Acquires 3,726 Shares of Humana Inc. $HUM - MarketBeat
3,146 Shares in Humana Inc. $HUM Purchased by Retireful LLC - MarketBeat
TriaGen Wealth Management LLC Purchases New Stake in Humana Inc. $HUM - MarketBeat
Humana Inc. $HUM Shares Sold by Cetera Investment Advisers - MarketBeat
Glenmark Will Pay $15.3M To End Humana's Price-Fixing Claims - Law360
CPI | Glenmark to Pay $15.3 Million to Settle Humana Antitrust Claims - PYMNTS.com
Can Humana Improve Caregiver Retention With HealthStream Deal? - The Globe and Mail
Equities Analysts Offer Predictions for Humana Q1 Earnings - MarketBeat
Humana (NYSE:HUM) Downgraded by Zacks Research to "Hold" - MarketBeat
Humana stock (HUM) climbs 3% as 2027 COLA calculations obscure rising medical-cost shortfall - TechStock²
Why Is Humana (NYSE:HUM) Betting Bigger on Medicaid and CenterWell? - Kalkine Media
Humana names new Medicaid president - The Business Journals
Medicare Will Spend More Than $13 Billion on the Medicare Advantage Quality Bonus Program in 2026 - KFF
Humana Inc. (HUM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Humana Inc (HUM) Stock Down 3.3% but Still Overvalued -- GF Scor - GuruFocus
Finanzdaten der Humana Inc-Aktie (HUM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Humana Inc-Aktie (HUM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Ventura Joseph C | Chief Legal Officer |
Feb 24 '26 |
Option Exercise |
0.00 |
1,035 |
0 |
17,565 |
| Renaudin George II | President, Insurance |
Feb 24 '26 |
Option Exercise |
0.00 |
1,035 |
0 |
16,494 |
| Felter John-Paul W. | SVP, Chief Accting Off & Cont. |
Feb 24 '26 |
Option Exercise |
0.00 |
165 |
0 |
7,568 |
| Shetty Sanjay K | President, CenterWell |
Feb 23 '26 |
Buy |
185.21 |
810 |
150,016 |
11,657 |
| Dintenfass David | President, Enterprise Growth |
Feb 21 '26 |
Option Exercise |
0.00 |
3,858 |
0 |
15,316 |
| Mehta Japan | Chief Information Officer |
Feb 13 '26 |
Option Exercise |
0.00 |
1,682 |
0 |
8,158 |
| Mellet Celeste | Chief Financial Officer |
Feb 13 '26 |
Option Exercise |
0.00 |
7,763 |
0 |
28,454 |
| Rechtin James A. | President & CEO |
Jan 08 '26 |
Option Exercise |
0.00 |
2,183 |
0 |
29,285 |
| O'Hara Michelle A. | Chief Human Resources Officer |
Jan 01 '26 |
Option Exercise |
0.00 |
2,353 |
0 |
10,634 |
| Mellet Celeste | Chief Financial Officer |
Dec 15 '25 |
Option Exercise |
0.00 |
2,128 |
0 |
29,676 |
2.38%
0.78%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):